Fundz

ImmuONE has secured £600,000 to advance its human lung model for drug testing. The funding will enable the biotech startup to enhance its capabilities and expand into new sectors.

PRIVATEMar 14, 2025

Amount Raised

£600,000

Round Type

Funding Round

StevenageBiotechnology

Investors

Pioneer GroupMercia VenturesMidlands Engine Investment Fund

Description

ImmuONE, a UK-based biotech startup, has raised £600,000 from Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group. This investment will help the company advance its animal testing alternative and grow its team. The latest funding brings the total raised by ImmuONE to £3.5M. The company aims to improve drug safety testing and reduce reliance on animal testing.

Quick answer

ImmuONE raised £600,000 in a Funding Round round, dated March 14, 2025. Investors: Pioneer Group, Mercia Ventures and Midlands Engine Investment Fund. ImmuONE is based in Stevenage, England, United Kingdom.

How much did ImmuONE raise?
ImmuONE raised £600,000 in a Funding Round round on March 14, 2025.
Who invested in ImmuONE?
Pioneer Group, Mercia Ventures and Midlands Engine Investment Fund are named as investors in this round.
What does ImmuONE do?
ImmuONE is a biotech startup founded in 2019 that addresses critical market needs in drug development and safety testing with its advanced 3D human lung model.
Where is ImmuONE based and how big is it?
ImmuONE is based in Stevenage, England, United Kingdom. Fundz records about 20 employees.
Who are the decision-makers at ImmuONE?
Fundz holds 1 contact at ImmuONE. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ImmuONE that raised within 45 days of this round, from Fundz verified event records.

  • Gestalt Diagnostics raised $7.5M (Series A) on April 28, 2025.
  • Fresenius Medical Care raised $4.4M on April 28, 2025.
  • Craif raised $22M (Series C) on April 28, 2025.
  • Cycuria Therapeutics raised an undisclosed amount (Grant) on April 28, 2025.
  • Oratech Pharmaceuticals raised $37M (Corporate Round) on April 28, 2025.
  • Avidicure raised $50M (Seed) on April 27, 2025.

Who to call at ImmuONE, and when

A new round usually means ImmuONE is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ImmuONE raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImmuONE, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImmuONE. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImmuONE

Location

Stevenage, England, United Kingdom

About

ImmuONE is a biotech startup founded in 2019 that addresses critical market needs in drug development and safety testing with its advanced 3D human lung model. The company develops a laboratory model that grows human lower lung tissue and immune cells, providing a more accurate and ethical alternative for inhalation safety testing. By focusing on delivering reliable results, ImmuONE aims to help companies transition away from animal testing and enhance their product testing methodologies. With a commitment to innovation, ImmuONE transforms academic research into practical solutions for various industries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImmuONE raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ImmuONE's next move

See what Strategic adds

ImmuONE raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.